Ferrous fumarate and Keratitis - a phase IV clinical study of FDA data

Summary:

Keratitis is reported as a side effect among people who take Ferrous fumarate (ferrous fumarate), especially for people who are female, 60+ old, also take Arava, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Keratitis when taking Ferrous fumarate. It is created by eHealthMe based on reports of 9,374 people who have side effects when taking Ferrous fumarate from the FDA, and is updated regularly.

What is Ferrous fumarate?

Ferrous fumarate has active ingredients of ferrous fumarate. It is often used in anemia. eHealthMe is studying from 9,840 Ferrous fumarate users. Check the latest studies of Ferrous fumarate.

What is Keratitis?

Keratitis (eye's cornea, the front part of the eye, becomes inflamed) is found to be associated with 417 drugs and 836 conditions by eHealthMe. Check the latest studies of Keratitis.

On Jul, 19, 2026

9,374 people reported to have side effects when taking Ferrous fumarate.
Among them, 25 people (0.27%) have Keratitis.

Among these 25 people:

What is the gender of people who have Keratitis when taking Ferrous fumarate? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Keratitis when taking Ferrous fumarate? *

What are other drugs people take besides Ferrous fumarate? *

Leflunomide: 25 people, 100.00%
Pantoprazole Sodium: 25 people, 100.00%
Folic Acid: 25 people, 100.00%
Erelzi: 25 people, 100.00%
Enbrel: 25 people, 100.00%
Hydroxychloroquine Sulfate: 25 people, 100.00%
Orencia: 25 people, 100.00%
Atenolol: 25 people, 100.00%
Remicade: 25 people, 100.00%
Arava: 25 people, 100.00%

What are other side effects people have besides Keratitis? *

Synovitis (inflammation of the synovial membrane): 25 people, 100.00%
Haemoglobin Decreased: 25 people, 100.00%
Impaired Healing: 25 people, 100.00%
Inflammatory Marker Increased: 25 people, 100.00%
Haematocrit Decreased: 25 people, 100.00%
Femur Fracture: 25 people, 100.00%
Fatigue (feeling of tiredness): 25 people, 100.00%
Multiple Fractures: 25 people, 100.00%
Fall: 25 people, 100.00%
Drug Intolerance (drug sensitivity): 25 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 25 people, 100.00%
Uveitis (inflammation of the uvea): 23 people, 92.00%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 23 people, 92.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 68.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ferrous fumarate and have Keratitis?

- Check whether Keratitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ferrous fumarate:

Ferrous fumarate (9,840 reports)

Keratitis treatments and more:

Keratitis (4,120 reports)

Browse all side effects of Ferrous fumarate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Keratitis:

Keratitis (417 drugs)

Browse all the conditions that are associated with Keratitis:

Keratitis (836 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ferrous fumarate (the active ingredients of Ferrous fumarate) and Ferrous fumarate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.